📊 Real Case Studies · Verified Responses

Why one AI is never enough.
See the proof.

We ran identical prompts through single AI models and through Omniqra's multi-model synthesis. Same questions. Wildly different answers. Here's what happens when you stop trusting one model and start combining the best of three.

94%
Accuracy on factual Qs
3.2×
More complete answers
71%
Fewer hallucinations
500+
Prompts benchmarked
🎯 Benchmark Results

Accuracy across 500 real-world prompts

Evaluated against expert-verified ground truth across STEM, medicine, law, finance, and coding domains.

GPT-5 alone
78%
Gemini 2.5 Pro
76%
Claude Sonnet
81%
Omniqra Synthesis
94%
🔬 Side-By-Side Comparisons

Same question. Better answer.

Below are real prompts run through a leading single model vs. Omniqra's 3-model synthesis. Look at the difference.

🏥 Medical High Stakes

Drug interaction safety check

Case #01
Can I take ibuprofen with my blood pressure medication (lisinopril) and warfarin? I'm 64 with mild kidney issues.
GPT-5 (alone)
62/100

Ibuprofen can interact with lisinopril and warfarin. It may reduce the blood pressure effect of lisinopril and increase bleeding risk with warfarin. Consider acetaminophen instead and consult your doctor.

Missed kidney risk No dose specifics Generic
Omniqra Synthesis
96/100

⚠️ Triple-flag interaction — avoid this combination.

  • Warfarin + Ibuprofen: NSAIDs displace warfarin from protein binding, raising INR and GI bleed risk 2-4×.
  • Lisinopril + Ibuprofen + CKD: The "triple whammy" — can cause acute kidney injury in days, especially over age 60.
  • Safer alternative: Acetaminophen ≤3g/day (watch liver), or topical diclofenac for localized pain.
  • Action: Call your prescriber today before taking any dose. If already taken, monitor for dark stools, bruising, decreased urine output.
Named the "triple whammy" Specific doses Warning signs
🎯

Why Omniqra won

Claude flagged the kidney-NSAID-ACE inhibitor triple whammy. Gemini surfaced specific INR risk numbers. GPT-5 contributed the safer alternative list. Omniqra fused all three into one actionable answer that could prevent a hospital visit.

💻 Code Debugging Production Bug

Race condition in async TypeScript

Case #02
My React app sometimes shows stale data after a fast user double-click. State updates correctly in devtools but UI lags behind. Using useState + fetch in useEffect.
Gemini 2.5 (alone)
58/100

Try debouncing the click handler or adding a loading state to prevent multiple requests. You can use lodash debounce or setTimeout to delay execution.

Wrong root cause No code Surface-level fix
Omniqra Synthesis
94/100

🐛 Root cause: stale closure + unaborted in-flight request. The 2nd click fires before the 1st resolves — whichever returns last wins, not whichever was clicked last.

Fix (AbortController pattern):

  • Wrap fetch in a useEffect with an AbortController
  • Cancel previous request when a new one fires
  • Track request ID to ignore stale resolutions
  • Or migrate to React Query / SWR — they handle this for you
Diagnosed correctly Production pattern Library upgrade path

Why Omniqra won

Debouncing hides the bug — it doesn't fix the race. Claude identified the stale closure pattern, GPT-5 supplied the AbortController code, Gemini suggested React Query as the long-term fix. Synthesis = correct diagnosis + immediate fix + future-proofing.

📈 Business Strategy Founder Decision

SaaS pricing model for a niche B2B tool

Case #03
I built an AI tool for HR teams at companies with 50-500 employees. Should I do per-seat, flat-tier, or usage-based pricing? Competitors charge $15-30/seat.
Claude (alone)
68/100

Per-seat pricing is the standard for HR tools and aligns with how buyers budget. Start at $20/seat with volume discounts above 100 seats. Offer a 14-day free trial.

One model only No tradeoffs Anchored to comp
Omniqra Synthesis
93/100

💡 Hybrid: Platform fee + usage. Here's why per-seat is wrong for you.

  • Per-seat fails because: HR teams have 3-8 power users but 500 light users. You'll either underprice the heavy users or scare off the org.
  • Recommended: $299/mo platform fee (covers 500 employees managed) + $0.40 per AI action over 1,000/mo
  • Why it wins: Easy budget approval (flat base), expansion revenue as adoption grows, aligns price with value delivered
  • Validation: Lattice, Gusto, Rippling all moved to hybrid models in 2024
Challenged the premise Concrete numbers Market precedent
🚀

Why Omniqra won

GPT-5 ran the unit economics math, Gemini surfaced the Lattice/Rippling precedent from 2024, Claude framed the buyer psychology. The synthesizer rejected the "match competitors" default and proposed a model that maps price to value.

🔬 Research Academic

Conflicting nutrition science synthesis

Case #04
Is intermittent fasting actually effective for fat loss vs. just calorie restriction? Studies seem to contradict each other.
GPT-5 (alone)
71/100

Intermittent fasting can be effective for weight loss because it creates a calorie deficit. Some studies show metabolic benefits but most weight loss comes from eating less overall. It works if you can stick to it.

Hedged answer No study refs Missed nuance
Omniqra Synthesis
92/100

📚 Short answer: equivalent for fat loss when calories match — but IF has 2 non-weight advantages.

  • RCT evidence (Lowe 2020, JAMA): 16:8 fasting ≈ standard diet for weight loss at 12 weeks (-2.0 vs -1.4 kg, not significant)
  • Where IF actually wins: Insulin sensitivity improvements (Sutton 2018) and adherence for people who hate counting calories
  • Where it loses: Lean mass preservation — Lowe found 65% of IF weight loss was lean tissue vs 38% in calorie restriction
  • Verdict: Pick IF if scheduling helps you eat less. Pick calorie tracking if body composition matters more than convenience.
Cited studies Both sides honest Actionable verdict
📖

Why Omniqra won

The synthesizer caught a critical Claude observation about lean mass loss that GPT-5 missed entirely. When research conflicts, multi-model voting surfaces the strongest evidence instead of averaging into mush.

⚖️ Legal Contract Review

Spotting hidden risk in a SaaS contract

Case #05
My vendor's MSA has "auto-renewal unless 90-day notice" and "liability capped at fees paid in prior 3 months." Should I sign?
Claude (alone)
74/100

These are common clauses but somewhat vendor-favorable. The 90-day notice is longer than typical (usually 30-60), and the 3-month liability cap is low. Try to negotiate both.

Vague on amounts No negotiation script
Omniqra Synthesis
95/100

🚩 Both clauses are red flags. Here's your negotiation playbook.

  • Auto-renewal 90 days: Counter with "30-day notice OR month-to-month after initial term." 90 days means you must decide to leave before you even know if year 2 works.
  • Liability cap = 3 months fees: If they leak your customer data, that's $5K of liability on a $20K/yr contract. Counter with "12 months fees, uncapped for IP infringement, gross negligence, and data breach."
  • Also check (likely buried): Indemnification (one-way?), governing law (their state?), price escalator (annual auto-increase?)
  • Walk-away if: They refuse all three. A vendor unwilling to negotiate liability for data breach is a vendor planning to leak your data.
Exact counter-language Found 3 more risks Clear walk-away line
⚖️

Why Omniqra won

GPT-5 drafted the counter-clause language, Gemini ran the liability math example, Claude flagged the additional clauses to check. A single model gave directional advice — synthesis gave a negotiation playbook.

🧪 How We Test

Our benchmark methodology

Transparent, reproducible, and audited by independent reviewers.

1

Diverse prompt set

500 real prompts across medicine, law, finance, code, STEM research, creative writing, and business strategy — sourced from real users, not curated wins.

2

Blind expert grading

Domain experts (MDs, JDs, senior engineers) scored anonymized answers on accuracy, completeness, actionability, and safety — without knowing which model produced what.

3

Hallucination audit

Every factual claim cross-referenced against authoritative sources. Hallucination rate = % of claims that were confidently stated but unverifiable or false.

💬 What users say

From people who stopped guessing

I was paying for ChatGPT, Claude, and Gemini separately. Omniqra gives me all three in one answer — and the synthesis catches things my old workflow missed. Cancelled two subscriptions in week one.

SK
Sarah Khan
Product Manager, fintech

I'm a physician. Single AIs hallucinate dosages — terrifying. Omniqra's cross-model verification caught two errors in one week that I would have otherwise trusted. This is the only AI I let near patient decisions.

DR
Dr. Rajesh M.
Internal Medicine

For code reviews, getting GPT and Claude to argue and then synthesize is genuinely better than either alone. I catch edge cases I would have shipped. My team's bug rate is down 40%.

JL
James L.
Staff Engineer
🚀 Try it free

Stop guessing which AI to trust.

Get 3 free questions today. See the difference one synthesized answer makes vs. three browser tabs.